NewBiologix has given a non-exclusive technology licence to Recipharm Advanced Bio to provide pharma companies access to ...

Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from ...

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...

Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To ...

Haya Therapeutics has secured $65m in Series A funding to expedite the clinical development of HTX-001 for treating heart ...

Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.

It is vital for biotech companies to run the right clinical trial and not cut costs, the Sanofi executive said.

The Vivo Opportunity Fund has already catalysed a plethora of medicine development via biotech investments in its first two ...

BioVaxys Technology and Sona Nanotech have signed an agreement to develop cancer therapeutics, utilising the DPX platform ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the United States.

At a time when investment has been low in biotech, establishing and maintaining good relationships with investors is vital.

Discussing AstraZeneca’s experience with the Project Orbis pathway, Sabine Ledderhose, head of regulatory affairs for the ...